Washington University researchers have received a $10.3 million grant renewal to continue a long-term study of adults who are more…
Articles by Ana de Barros, PhD
The Alzheimer’s Foundation of America (AFA) will soon launch its 2018 “Educating America” tour to bring educational conferences on…
Takeda Pharmaceutical Company and Denali Therapeutics are teaming up to develop three treatments for Alzheimer’s disease and other neurodegenerative…
Servier and Treventis will work together on therapies that can circumvent the misfolded proteins involved in Alzheimer’s and other neurodegenerative…
Four ways of possibly preventing dementia late in life — prescription medicines, over-the-counter (OTC) supplements and vitamins, physical activity, and cognitive…
Aricept (donepezil hydrochloride) is now approved in China to treat patients with severe Alzheimer’s disease, as well as those…
Marriage appears to be a strong and favorable factor in a person’s risk of developing dementia, with evidence suggesting…
Canadian researchers have developed a simple tool to track cognitive performance, so doctors can identify those at higher risk of…
Probiodrug and Crossbeta Biosciences are extending a partnership that Probiodrug believes will help it continue developing a potential Alzheimer’s therapy.
The number of Americans with Alzheimer’s disease or mild cognitive impairment, which can be a precursor to the disease,…